Mechanism Comparison · Central vs Peripheral

Central vs. Peripheral Mechanisms

The distinction between neurological and vascular sexual response mechanisms is clinically significant. These two compound classes act at entirely different anatomical and pharmacological levels.

Central Mechanism

PT-141 · Bremelanotide

Activates hypothalamic MC4R receptors

Initiates top-down neural signaling

Engages limbic and dopaminergic pathways

Produces CNS-mediated arousal readiness

Onset: 30–60 min (subcutaneous)

Functions independent of stimulation context

Peripheral Mechanism

PDE5 Inhibitors · e.g. Sildenafil

Inhibits PDE5 enzyme in vascular smooth muscle

Increases cGMP → vasodilation

Enhances blood flow to genital tissues

Produces peripheral vascular response

Onset: 30–60 min (oral)

Requires sexual stimulation to activate

ParameterPT-141 (Central)PDE5 Inhibitor (Peripheral)

Activation SiteHypothalamus / CNSPenile / Genital vasculature

Primary ReceptorMC4R (GPCR)PDE5 enzyme

Mechanism ClassNeuromodulatoryVasodilatory

Stimulation RequiredNoYes

Psychological ActivationCentrally mediatedIndirectly only

Blood Flow DependencyNone (CNS-initiated)Direct mechanism

Primary Latency~30–60 min post-SC~30–60 min post-oral

Primary PathwayMelanocortin → dopamine axiscGMP → NO pathway

FDA IndicationHSDD (premenopausal women)Erectile dysfunction

Interpretive note: These mechanisms are not mutually exclusive in clinical populations. Patients may use central and peripheral agents independently for distinct pharmacological objectives. No head-to-head clinical trial data exists comparing PT-141 to PDE5 inhibitors on matched endpoints.